BRIEF-Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer

Reuters
11 Apr
BRIEF-Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer

April 10 (Reuters) - Shuttle Pharmaceuticals Holdings Inc SHPH.O:

  • SHUTTLE PHARMACEUTICALS- FILES PROVISIONAL PATENT APPLICATION FOR PSMA LIGAND CONJUGATES TO TREAT PROSTATE CANCER

Source text: ID:nGNX24fc7c

Further company coverage: SHPH.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10